• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以吸烟状况为重点的中国晚期非小细胞肺癌患者生存预后因素:一项对4552例患者的地区性单机构回顾性分析。

Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients.

作者信息

Hu Qiong, Li Bing, Garfield David, Ren Shengxiang, Li Aiwu, Chen Xiaoxia, Zhou CaiCun

机构信息

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China Tongji University Medical School Cancer Institute, Shanghai, China ProMed Cancer Center, Shanghai, China.

出版信息

Thorac Cancer. 2012 May;3(2):162-168. doi: 10.1111/j.1759-7714.2011.00099.x.

DOI:10.1111/j.1759-7714.2011.00099.x
PMID:28920299
Abstract

BACKGROUND

Lung cancer ranks as the top of cancer-related mortality in the world. Approximately 85-90% of all lung cancer cases are non-small cell lung cancer (NSCLC). For advanced NSCLC patients, the five-year survival rate is less than 5%. Previous studies have attempted to determine prognostic factors, such as smoking status, gender, ethnicity, age, and histological type. However, the results are controversial and conflict. In this study, we investigated prognostic factors in a Chinese population presenting with advanced NSCLC.

METHODS

Medical records of patients with advanced NSCLC (AJCC Stage IIIB/IV) who received treatment at our institution were reviewed. Kaplan-Meier method and Cox Proportional Hazards model were performed in both univariate and multivariate analyses.

RESULTS

A total of 4552 patients were entered. Among them, 1320 (29.0%) were female, 2408 non-smokers (52.9%), and all had Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0/1. Univariate analysis suggested that female gender (P < 0.001), adenocarcinoma histology (P < 0.001), age <70 (P < 0.001), and non-smoker status (P < 0.001) were associated with better survival. However, multivariate analysis demonstrated that age (hazard ratio [HR]= 1.173, 95% confidence interval [CI]: 1.085-1.268, P < 0.001), smoking status (vs. non-smokers, HR = 1.212, 95% CI: 1.123-1.308, P < 0.001), and histological type (non-adenocarcinoma vs. adenocarcinoma, HR = 1.104, 95% CI: 1.031-1.181, P = 0.004), but not gender, were independent prognostic factors.

CONCLUSIONS

Smoking status, age, and histological type are independent prognostic factors in Chinese NSCLC patients presenting with advanced disease. Non-smoking status is associated with better overall survival in Chinese NSCLC patients.

摘要

背景

肺癌是全球癌症相关死亡率最高的疾病。所有肺癌病例中约85 - 90%为非小细胞肺癌(NSCLC)。对于晚期NSCLC患者,五年生存率低于5%。先前的研究试图确定预后因素,如吸烟状况、性别、种族、年龄和组织学类型。然而,结果存在争议且相互矛盾。在本研究中,我们调查了中国晚期NSCLC患者的预后因素。

方法

回顾了在我们机构接受治疗的晚期NSCLC(美国癌症联合委员会[AJCC] IIIB/IV期)患者的病历。采用Kaplan-Meier法和Cox比例风险模型进行单因素和多因素分析。

结果

共纳入4552例患者。其中,女性1320例(29.0%),非吸烟者2408例(52.9%),所有患者东部肿瘤协作组(ECOG)体能状态(PS)均为0/1。单因素分析表明,女性(P < 0.001)、腺癌组织学类型(P < 0.001)、年龄<70岁(P < 0.001)和非吸烟状态(P < 0.001)与较好的生存率相关。然而,多因素分析显示,年龄(风险比[HR]= 1.173,95%置信区间[CI]:1.085 - 1.268,P < 0.001)、吸烟状况(与非吸烟者相比,HR = 1.212,95% CI:1.123 - 1.308,P < 0.001)和组织学类型(非腺癌与腺癌相比,HR = 1.104,95% CI:1.031 - 1.181,P = 0.004)是独立的预后因素,而性别不是。

结论

吸烟状况、年龄和组织学类型是中国晚期NSCLC患者的独立预后因素。非吸烟状态与中国NSCLC患者较好的总生存率相关。

相似文献

1
Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients.以吸烟状况为重点的中国晚期非小细胞肺癌患者生存预后因素:一项对4552例患者的地区性单机构回顾性分析。
Thorac Cancer. 2012 May;3(2):162-168. doi: 10.1111/j.1759-7714.2011.00099.x.
2
Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.体能状态和吸烟状态是非小细胞肺癌生存的独立有利预后因素:对 26957 例非小细胞肺癌患者的综合分析。
J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9.
3
Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.C反应蛋白和吸烟对接受一线姑息化疗的晚期非小细胞肺癌患者的预后意义
J Thorac Oncol. 2009 Mar;4(3):326-32. doi: 10.1097/JTO.0b013e31819578c8.
4
Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.性别、组织学和诊断时间是预后的重要因素:对日本 1499 例晚期非小细胞肺癌从不吸烟患者的分析。
J Thorac Oncol. 2010 Jul;5(7):1011-7. doi: 10.1097/JTO.0b013e3181dc213e.
5
Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.组织学和吸烟状况预测晚期非小细胞肺癌患者的生存。西日本肿瘤学组(WJOG)研究 3906L 的结果。
J Thorac Oncol. 2013 Jun;8(6):753-8. doi: 10.1097/JTO.0b013e31828b51f5.
6
Prognostic factors in older patients with advanced non-small cell lung cancer in China.中国老年晚期非小细胞肺癌患者的预后因素
Tumori. 2014 Jan-Feb;100(1):69-74. doi: 10.1700/1430.15818.
7
The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.非小细胞肺癌中从不吸烟者与曾经吸烟者之间的临床病理及生存差异。
J BUON. 2014 Apr-Jun;19(2):453-8.
8
Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.IIIb 期-IV 期非小细胞肺癌患者 Charlson 合并症指数评分与结局的相关性。
BMC Pulm Med. 2017 Aug 15;17(1):112. doi: 10.1186/s12890-017-0452-0.
9
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.吸烟会影响晚期非小细胞肺癌患者的治疗效果。
Cancer. 2006 Jun 1;106(11):2428-36. doi: 10.1002/cncr.21884.
10
Prognostic factors after complete resection of pN2 non-small cell lung cancer.pN2 期非小细胞肺癌完全切除术后的预后因素。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):788-95. doi: 10.1016/j.jtcvs.2013.04.043. Epub 2013 Jun 27.

引用本文的文献

1
Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.SMARCA4 缺陷型非小细胞肺癌的临床特征和预后分析。
Cancer Med. 2023 Jul;12(13):14171-14182. doi: 10.1002/cam4.6083. Epub 2023 May 15.
2
LncRNA HCG11 Suppresses Cell Proliferation and Promotes Apoptosis via Sponging miR-224-3p in Non-Small-Cell Lung Cancer Cells.长链非编码RNA HCG11通过海绵吸附miR-224-3p抑制非小细胞肺癌细胞增殖并促进其凋亡
Onco Targets Ther. 2020 Jul 3;13:6553-6563. doi: 10.2147/OTT.S244181. eCollection 2020.
3
Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
酮体途径中 PLIN2、SULT2A1 和 UGT1A9 基因的潜在功能遗传变异与非小细胞肺癌的生存。
Int J Cancer. 2020 Sep 15;147(6):1559-1570. doi: 10.1002/ijc.32932. Epub 2020 Mar 9.
4
γ -H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer.γ-H2AX:早期可手术非小细胞肺癌患者预后预测模型中的一个新的预后标志物。
Int J Genomics. 2014;2014:160236. doi: 10.1155/2014/160236. Epub 2014 Jan 8.